Comparison of Costs and Health Resource Utilization inPatients Treated with Different Disease Modifying Therapies for MultipleSclerosis

被引：0
|
作者：
Nicholas, Jacqueline [4 ]
Boster, Aaron
Yeh, Wei-Shi [1 ]
Garland, Robert [2 ]
Fay, Monica [3 ]
Iyer, Ravi [2 ]
Lee, Andrew [2 ]
机构：
[1] Biogen, Cambridge, MA USA
[2] Biogen, Global Market Access, Cambridge, MA USA
[3] Biogen, Med Affairs, Cambridge, MA USA
[4] Riverside Methodist Hosp, OhioHlth Multiple Sclerosis Ctr, Columbus, OH 43214 USA
来源：
NEUROLOGY | 2016年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P3.082
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Health care costs and resource utilization for different asthma severity stages in Colombia: a claims data analysis
    Florez-Tanus, Alvaro
    Parra, Devian
    Zakzuk, Josefina
    Caraballo, Luis
    Alvis-Guzman, Nelson
    [J]. WORLD ALLERGY ORGANIZATION JOURNAL, 2018, 11
  • [42] Exacerbations, Health Resource Utilization, and Costs Among Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease Treated with Nebulized Arformoterol Following a Respiratory Event
    Navaie, Maryam
    Celli, Bartolome R.
    Xu, Zhun
    Cho-Reyes, Soojin
    Dembek, Carole
    Gilmer, Todd P.
    [J]. CHRONIC OBSTRUCTIVE PULMONARY DISEASES-JOURNAL OF THE COPD FOUNDATION, 2019, 6 (04): : 297 - 307
  • [43] Persistence, Health Care Resource Utilization, and Costs Among OnabotulinumtoxinA-Treated Patients with Cervical Dystonia in the US
    Dashtipour, K.
    Charles, D.
    Sadeghi, M.
    Heath, M.
    Rava, A.
    Liu, J.
    Sun, H.
    Dong, Y.
    Lee, J.
    [J]. MOVEMENT DISORDERS, 2023, 38 : S345 - S346
  • [44] Persistence, Health Care Resource Utilization, and Costs Among OnabotulinumtoxinA-Treated Patients With Cervical Dystonia in the US
    Dashtipour, Khashayar
    Sadeghi, Marjan
    Heath, Maria
    Rava, Andrew
    Liu, Jinjie
    Sun, Haiyan
    Dong, Yanan
    Lee, Jae
    [J]. TOXICON, 2024, 237 : 21 - 21
  • [45] Health care resource utilization and disease modifying treatment use in multiple sclerosis patients by age and insurance type
    Cisternas, Miriam
    Bartolome, Lauren
    Gitar, Bret
    Hulbert, Erin
    Trenz, Helen
    Patel, Vikram
    Johnson, Kristen
    Russo, Patricia A.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (04) : 597 - 604
  • [46] Comparison of costs of different biologic therapies after dose optimisation
    Borzan, V.
    Fric, V. Orsic
    Borzan, B.
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S503 - S503
  • [47] Comparison of Costs and Health Care Resource Utilization (HRU) in Chronic Lymphocytic Leukemia (CLL) Patients Treated with Venetoclax (VEN) or Chemotherapy (CT)/Chemoimmunotherapy (CIT)
    Nabhan, Chadi
    Mato, Anthony R.
    Kish, Jonathan K.
    Nero, Damion
    [J]. BLOOD, 2018, 132
  • [48] Comparison of Health Care Utilization and Costs Among Patients With Fistulizing Crohn's Disease Treated with Biologics with or without Prior Seton Procedure
    Schwartz, David
    Eichner, Samantha
    Lin, Jay
    Yang, Mei
    Skup, Martha
    Chao, Jingdong
    Mulani, Parvez
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S625 - S625
  • [49] COMPARISON OF DISEASE AGNOSTIC HEALTHCARE RESOURCE UTILIZATION AND COSTS ACROSS THE US AND EU5 POPULATION
    Silber, A.
    Oak, B.
    Kulkarni, A.
    Goswami, L.
    Kataria, D.
    O'Hara, M.
    Hadker, N.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S138 - S138
  • [50] HEALTH CARE RESOURCE UTILIZATION AND REHOSPITALIZATION COSTS OF NEBULIZED ARFORMOTEROL FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Bollu, V
    Carlton, R.
    Clark, R. S.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A173 - A173
12345